{
    "status": "ok",
    "totalResults": 17,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Kaskela Law",
            "title": "SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of T2 Biosystems, Inc. (NASDAQ: TTOO) and Encourages Investors to Contact the Firm",
            "description": "PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating T2 Biosystems, Inc. (NASDAQ: TTOO) (\u201cT2\u201d) on behalf of the company\u2019s investors.",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2753039/0/en/SHAREHOLDER-ALERT-Kaskela-Law-LLC-Announces-Investigation-of-T2-Biosystems-Inc-NASDAQ-TTOO-and-Encourages-Investors-to-Contact-the-Firm.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/46a37084-e0b3-48fa-b515-02e82ff9d30a",
            "publishedAt": "2023-10-02T16:30:00Z",
            "content": "PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating T2 Biosystems, Inc. (NASDAQ: TTOO) (T2) on behalf of the companys investors.\r\nSince October 2022, sh\u2026 [+1222 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Thinking about buying stock in T2 Biosystems, Lucid Group, Femasys, Groupon Inc, or Phio Pharmaceuticals?",
            "description": "(marketscreener.com) \n\nNEW YORK, Oct. 13, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTOO, LCID, FEMY, GRPN, and PHIO.\n\n \n \n \n \n \n \n\n \nTo see how InvestorsObserver's proprietary scoring system rates these stocks, view the...h\u2026",
            "url": "https://www.marketscreener.com/quote/stock/T2-BIOSYSTEMS-INC-17122708/news/Thinking-about-buying-stock-in-T2-Biosystems-Lucid-Group-Femasys-Groupon-Inc-or-Phio-Pharmaceuti-45060764/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-13T13:32:05Z",
            "content": "NEW YORK, Oct. 13, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTOO, LCID, FEMY, GRPN, and PHIO.\r\nTo see how InvestorsObserver's proprietary scoring system rates thes\u2026 [+1559 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "T2 Biosystems, Inc.",
            "title": "T2 Biosystems Reports Granting of Inducement Award",
            "description": "LEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to four new employees.",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744244/32489/en/T2-Biosystems-Reports-Granting-of-Inducement-Award.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/21ce43b1-81a5-42af-8c47-c2df2e179d21",
            "publishedAt": "2023-09-15T20:05:00Z",
            "content": "LEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards t\u2026 [+2328 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "T2 Biosystems, Inc.",
            "title": "T2 Biosystems Reports Granting of Inducement Award",
            "description": "LEXINGTON, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to nine new employees.",
            "url": "https://www.globenewswire.com/news-release/2023/10/06/2756309/32489/en/T2-Biosystems-Reports-Granting-of-Inducement-Award.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/21ce43b1-81a5-42af-8c47-c2df2e179d21",
            "publishedAt": "2023-10-06T20:07:00Z",
            "content": "LEXINGTON, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to \u2026 [+2345 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "benzinga.com",
            "title": "Why T2 Biosystems Stock Fell Today",
            "description": "T2 Biosystems, Inc. TTOO shares traded lower Tuesday as the stock pulled back following Monday's strength after the FDA cleared the company's biothreat panel for commercial distribution. What To Know: Shares of T2 Biosystems received a boost Monday following \u2026",
            "url": "https://biztoc.com/x/d42f0dae2ba6734b",
            "urlToImage": "https://c.biztoc.com/p/d42f0dae2ba6734b/s.webp",
            "publishedAt": "2023-09-19T23:13:06Z",
            "content": "T2 Biosystems, Inc. TTOO shares traded lower Tuesday as the stock pulled back following Monday's strength after the FDA cleared the company's biothreat panel for commercial distribution.What To Know:\u2026 [+252 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "marketwatch.com",
            "title": "T2 Biosystems\u2019 stock extends losing streak despite FDA approval for anthrax and plague diagnostic test",
            "description": "Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO announced that it has received 510(k) clearance from the FD\u2026",
            "url": "https://biztoc.com/x/83f3c99837771bfa",
            "urlToImage": "https://c.biztoc.com/p/83f3c99837771bfa/s.webp",
            "publishedAt": "2023-09-20T21:52:12Z",
            "content": "Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test.In a statement Tuesday, T2 Biosystems TTOO \u2026 [+254 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "T2 Biosystems : Modification to Rights of Security Holders - Form 8-K",
            "description": "(marketscreener.com) \n \n \n \n Item\u20093.03\n \n \n \n Material Modification to Rights of Security Holders.\n \n \n \n \n \n To the extent required by Item 3.03 of Form 8-K, theinformation contained in Item 5.03 of this Current Report on Form 8-K...https://www.marketscreene\u2026",
            "url": "https://www.marketscreener.com/quote/stock/T2-BIOSYSTEMS-INC-17122708/news/T2-Biosystems-Modification-to-Rights-of-Security-Holders-Form-8-K-45053379/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-12T20:05:02Z",
            "content": "Alliance Global Partners Adjusts Price Target on T2 Biosystems to 7 cents From 12 cents, Maintains Neutral Rating\r\nJuly 13, 2023 at 10:56 am EDT"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "benzinga.com",
            "title": "What's Going On With T2 Biosystems Stock Today?",
            "description": "T2 Biosystems, Inc. TTOO shares are trading lower Monday. The stock has fallen more than 50% over the last five days. What To Know: An SEC filing shows a large insider sale of TTOO shares last week. According to the filing, CR Group, L.P. sold more than 10 mi\u2026",
            "url": "https://biztoc.com/x/660d4223044dc02f",
            "urlToImage": "https://c.biztoc.com/p/660d4223044dc02f/s.webp",
            "publishedAt": "2023-09-25T17:14:12Z",
            "content": "T2 Biosystems, Inc. TTOO shares are trading lower Monday. The stock has fallen more than 50% over the last five days.What To Know:An SEC filing shows a large insider sale of TTOO shares last week. Ac\u2026 [+284 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "marketwatch.com",
            "title": "T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says",
            "description": "T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone that could alter its near-term future, according to one analyst. Ben Haynor, an analyst at Alliance G\u2026",
            "url": "https://biztoc.com/x/ae03faa4f5994d6d",
            "urlToImage": "https://c.biztoc.com/p/ae03faa4f5994d6d/s.webp",
            "publishedAt": "2023-09-20T18:36:06Z",
            "content": "T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone that could alter its near-term future, ac\u2026 [+288 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "T2 Biosystems, Inc.",
            "title": "T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023",
            "description": "LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report preliminary financial results for the third\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755776/32489/en/T2-Biosystems-to-Report-Preliminary-Third-Quarter-2023-Financial-Results-and-Business-Updates-on-October-12-2023.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/21ce43b1-81a5-42af-8c47-c2df2e179d21",
            "publishedAt": "2023-10-05T20:05:00Z",
            "content": "LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today tha\u2026 [+1582 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "marketwatch.com",
            "title": "T2 Biosystems reaches regulatory milestone that could be a game changer: analyst",
            "description": "T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone that could alter its near-term future, according to one analyst. Ben Haynor, an analyst at Alliance G\u2026",
            "url": "https://biztoc.com/x/6f9683bdd73b2404",
            "urlToImage": "https://c.biztoc.com/p/6f9683bdd73b2404/og.webp",
            "publishedAt": "2023-09-21T02:50:08Z",
            "content": "T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone that could alter its near-term future, ac\u2026 [+256 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Thinking about buying stock in Murphy Canyon Acquisition Corp, Alliance Entertainment Holding, Fitell Corp, T2 Biosystems, or Aurora Cannabis?",
            "description": "(marketscreener.com) \n\nNEW YORK, Sept. 21, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MURF, AENT, FTEL, TTOO, and ACB.\n\n \n \n \n \n \n \n\n \nTo see how InvestorsObserver's proprietary scoring system rates these stocks, view the...h\u2026",
            "url": "https://www.marketscreener.com/quote/stock/T2-BIOSYSTEMS-INC-17122708/news/Thinking-about-buying-stock-in-Murphy-Canyon-Acquisition-Corp-Alliance-Entertainment-Holding-Fitel-44896586/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-21T13:32:10Z",
            "content": "NEW YORK, Sept. 21, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MURF, AENT, FTEL, TTOO, and ACB.\r\nTo see how InvestorsObserver's proprietary scoring system rates thes\u2026 [+1594 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "T2 Biosystems, Inc.",
            "title": "T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii",
            "description": "LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),\u00a0a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket notification to the U.\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2759640/32489/en/T2-Biosystems-Announces-FDA-510-k-Submission-to-Expand-the-Pathogen-Detection-on-its-FDA-Cleared-T2Bacteria-Panel-to-Include-Detection-of-Acinetobacter-baumannii.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/21ce43b1-81a5-42af-8c47-c2df2e179d21",
            "publishedAt": "2023-10-12T20:02:00Z",
            "content": "LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),\u00a0a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced tha\u2026 [+6353 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "T2 Biosystems, Inc.",
            "title": "T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates",
            "description": "Received FDA 510(k) clearance for the T2Biothreat Panel and significantly strengthened balance sheet Received FDA 510(k) clearance for the T2Biothreat Panel and significantly strengthened balance sheet",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2759653/32489/en/T2-Biosystems-Announces-Preliminary-Third-Quarter-2023-Financial-Results-and-Business-Updates.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/21ce43b1-81a5-42af-8c47-c2df2e179d21",
            "publishedAt": "2023-10-12T20:05:00Z",
            "content": "LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO) (the Company), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today\u2026 [+9253 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "MarketWatch"
            },
            "author": "James Rogers",
            "title": "T2 Biosystems\u2019 stock extends losing streak despite FDA approval for anthrax and plague diagnostic test",
            "description": "T2 Biosystems has received FDA clearance to market and sell its T2Biothreat panel",
            "url": "https://www.marketwatch.com/story/t2-biosystems-stock-extends-losing-streak-despite-fda-approval-for-anthrax-and-plague-diagnostic-test-8f29d981",
            "urlToImage": "https://images.mktw.net/im-700928/social",
            "publishedAt": "2023-09-20T20:50:00Z",
            "content": "Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test.\r\nIn a statement Tuesday, T2 Biosystems TTO\u2026 [+257 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "MarketWatch"
            },
            "author": "Ciara Linnane",
            "title": ": T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says",
            "description": "T2 has FDA clearance for its T2Biothreat panel, which can detect six deadly pathogens within four hours",
            "url": "https://www.marketwatch.com/story/t2-biosystems-reaches-regulatory-milestone-that-could-be-a-game-changer-analyst-says-5cee157",
            "urlToImage": "https://images.mktw.net/im-855165/social",
            "publishedAt": "2023-09-20T18:06:59Z",
            "content": "T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone that could alter its near-term future, ac\u2026 [+327 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Ana Roca-Umbert, Jorge Garcia-Calleja, Marina Vogel-Gonz\u00e1lez, Alejandro Fierro-Villegas, Gerard Ill-Raga, V\u00edctor Herrera-Fern\u00e1ndez, Anja Bosnjak, Gerard Muntan\u00e9, Esteban Guti\u00e9rrez, Felix Campelo, Rub\u00e9n Vicente, Elena Bosch",
            "title": "Human genetic adaptation related to cellular zinc homeostasis",
            "description": "Author summary Contrasting continental signatures of positive natural selection have been previously found in the human SLC30A9 gene encoding the protein ZnT9, which transports zinc across cell membranes. Here we investigate the genetic variants that have bee\u2026",
            "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1010950",
            "urlToImage": "https://journals.plos.org/plosgenetics/article/figure/image?id=10.1371/journal.pgen.1010950.g005&size=inline",
            "publishedAt": "2023-09-25T14:00:00Z",
            "content": "Citation: Roca-Umbert A, Garcia-Calleja J, Vogel-Gonz\u00e1lez M, Fierro-Villegas A, Ill-Raga G, Herrera-Fern\u00e1ndez V, et al. (2023) Human genetic adaptation related to cellular zinc homeostasis. PLoS Gene\u2026 [+83038 chars]"
        }
    ]
}